Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck.

ABSTRACT: The demographics of squamous cell carcinoma of the head and neck (SCCHN) is marked by a growing number of patients aged 65 and over, which is in line with global projections for other cancer types. In developed countries, more than half of new SCCHN cases are diagnosed in older people, and in 15 years from now, the proportion is expected to rise by more than 10%. Still, a high-level evidence-based consensus to guide the clinical decision process is strikingly lacking. The available data from retrospective studies and subset analyses of prospective trials suffer from a considerable underrepresentation of senior participants. The situation is even more challenging in the recurrent and/or metastatic setting, where usually only palliative measures are employed. Nevertheless, it is becoming cle

SUBMITTER: Szturz P 

PROVIDER: S-EPMC5006317 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature